Literature DB >> 10322315

Brain iNOS: current understanding and clinical implications.

J Licinio1, P Prolo, S M McCann, M L Wong.   

Abstract

Nitric oxide (NO) is a unique informational substance first identified as the endothelium-derived relaxing factor. It is generated by NO synthases and plays a prominent role in controlling a variety of organ functions in the cardiovascular, immune, reproductive and nervous systems. Inducible nitric oxide synthase (iNOS) is not normally present in the brain in youth but it can be detected in the brain after inflammatory, infectious or ischemic damage, as well as in the normal, aging brain. Brain iNOS seems to contribute to the pathophysiology of many diseases that involve the central nervous system, but the role of iNOS appears to go beyond tissue damage. Brain iNOS might be required for adequate repair following injury or damage. The effects of brain iNOS on the balance between damage and repair make this enzyme a promising therapeutic target in human disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10322315     DOI: 10.1016/S1357-4310(99)01453-7

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  32 in total

1.  A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea-pig suprachiasmatic nucleus.

Authors:  S J Starkey; A L Grant; R M Hagan
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats.

Authors:  Hong-Xia Niu; Jun-Zhe Wang; Dong-Liang Wang; Jun-Jie Miao; Hua Li; Zhi-Gang Liu; Xing Yuan; Wei Liu; Jing-Ru Zhou
Journal:  Cell Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.046

3.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

4.  Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells.

Authors:  Regis Zimmer; Peter Thomas
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis.

Authors:  Ranjan Rajendram; Sindhu Saraswathy; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

Review 6.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

7.  Effects of Modafinil on Clonic Seizure Threshold Induced by Pentylenetetrazole in Mice: Involvement of Glutamate, Nitric oxide, GABA, and Serotonin Pathways.

Authors:  Erfan Bahramnjead; Soheil Kazemi Roodsari; Nastaran Rahimi; Payam Etemadi; Iraj Aghaei; Ahmad Reza Dehpour
Journal:  Neurochem Res       Date:  2018-08-25       Impact factor: 3.996

8.  Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway.

Authors:  Zheng Li; Qian-Qian Ma; Yan Yan; Feng-Dan Xu; Xiao-Ying Zhang; Wei-Qin Zhou; Zhi-Chun Feng
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

9.  Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Kerstin A Goth; Nemani V Prasadarao
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

10.  Elevated nitric oxide levels in childhood brain tumors.

Authors:  Chung-Lan Kao; Shih-Hwa Chiou; Hong-Shin Chen; Donald Ming-Tak Ho; Chieh-Fu Chen; Larry L-T Ho; Meng-Jer Lee; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2003-09-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.